Over the past two decades, many new treatment options have been introduced for type 2 diabetes. Increasingly, there is debate regarding the effectiveness of insulin as the last-line therapy. While diabetes control has improved over the past two decades (1) (2) (3) , a substantial portion of patients is still not meeting the clinical targets. To examine national trends in glycemic control by insulin and oral diabetes medication use, we conducted a cross-sectional study of 4,947 adult participants with diagnosed diabetes (all types) in the National Health and Nutrition Examination Survey (NHANES) in the 1988-1994 and 1999-2012 cycles. The NHANES surveys are cross-sectional, complex probability samples of the U.S. civilian noninstitutionalized population. All NHANES protocols were approved by an institutional review board, and informed consent was obtained from participants. Hemoglobin A 1c (HbA 1c ) was measured in whole blood samples using high-performance liquid chromatography methods performed on instruments certified by the NGSP and standardized to the reference method used in the Diabetes Control and Complications Trial (DCCT). We calibrated the HbA 1c values to account for changes in measurement methods over the 20 years of data collection in NHANES (1) NHANES 1988 NHANES -1994 NHANES , 1999 NHANES -2004 NHANES , and 2005 NHANES -2012 NHANES 1988 NHANES -1994 
